135 related articles for article (PubMed ID: 37685762)
1. Biomarkers of Collagen Metabolism Are Associated with Left Ventricular Function and Prognosis in Dilated Cardiomyopathy: A Multi-Modal Study.
Raafs AG; Adriaans BP; Henkens MTHM; Verdonschot JAJ; Abdul Hamid MA; Díez J; Knackstedt C; van Empel VPM; Brunner-La Rocca HP; González A; Wildberger JE; Heymans SRB; Hazebroek MR
J Clin Med; 2023 Sep; 12(17):. PubMed ID: 37685762
[TBL] [Abstract][Full Text] [Related]
2. Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial.
Ravassa S; Trippel T; Bach D; Bachran D; González A; López B; Wachter R; Hasenfuss G; Delles C; Dominiczak AF; Pieske B; Díez J; Edelmann F
Eur J Heart Fail; 2018 Sep; 20(9):1290-1299. PubMed ID: 29709099
[TBL] [Abstract][Full Text] [Related]
3. Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure.
López B; Ravassa S; González A; Zubillaga E; Bonavila C; Bergés M; Echegaray K; Beaumont J; Moreno MU; San José G; Larman M; Querejeta R; Díez J
J Am Coll Cardiol; 2016 Jan; 67(3):251-60. PubMed ID: 26796388
[TBL] [Abstract][Full Text] [Related]
4. The combination of carboxy-terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy - A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy.
Raafs AG; Verdonschot JAJ; Henkens MTHM; Adriaans BP; Wang P; Derks K; Abdul Hamid MA; Knackstedt C; van Empel VPM; Díez J; Brunner-La Rocca HP; Brunner HG; González A; Bekkers SCAM; Heymans SRB; Hazebroek MR
Eur J Heart Fail; 2021 Jun; 23(6):933-944. PubMed ID: 33928704
[TBL] [Abstract][Full Text] [Related]
5. Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
Yang C; Qiao S; Song Y; Liu Y; Tang Y; Deng L; Yuan J; Hu F; Yang W
Cardiovasc Pathol; 2019; 43():107150. PubMed ID: 31639652
[TBL] [Abstract][Full Text] [Related]
6. Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients.
Raafs AG; Boscutti A; Henkens MTHM; van den Broek WWA; Verdonschot JAJ; Weerts J; Stolfo D; Nuzzi V; Manca P; Hazebroek MR; Knackstedt C; Merlo M; Heymans SRB; Sinagra G
J Am Heart Assoc; 2022 Mar; 11(6):e024505. PubMed ID: 35253464
[TBL] [Abstract][Full Text] [Related]
7. Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome.
Ravassa S; López B; Querejeta R; Echegaray K; San José G; Moreno MU; Beaumont FJ; González A; Díez J
J Hypertens; 2017 Apr; 35(4):853-861. PubMed ID: 28253222
[TBL] [Abstract][Full Text] [Related]
8. Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy.
Rubiś P; Wiśniowska-Śmialek S; Wypasek E; Biernacka-Fijalkowska B; Rudnicka-Sosin L; Dziewiecka E; Faltyn P; Khachatryan L; Karabinowska A; Kozanecki A; Tomkiewicz-Pająk L; Podolec P
Inflamm Res; 2016 Dec; 65(12):941-949. PubMed ID: 27516211
[TBL] [Abstract][Full Text] [Related]
9. Circulating markers of collagen types I, III, and IV in patients with dilated cardiomyopathy: relationships with myocardial collagen expression.
Nagao K; Inada T; Tamura A; Kajitani K; Shimamura K; Yukawa H; Aida K; Sowa N; Nishiga M; Horie T; Makita T; Ono K; Tanaka M
ESC Heart Fail; 2018 Dec; 5(6):1044-1051. PubMed ID: 30273997
[TBL] [Abstract][Full Text] [Related]
10. Left Atrial Strain Has Superior Prognostic Value to Ventricular Function and Delayed-Enhancement in Dilated Cardiomyopathy.
Raafs AG; Vos JL; Henkens MTHM; Slurink BO; Verdonschot JAJ; Bossers D; Roes K; Gerretsen S; Knackstedt C; Hazebroek MR; Nijveldt R; Heymans SRB
JACC Cardiovasc Imaging; 2022 Jun; 15(6):1015-1026. PubMed ID: 35680209
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of Collagen Carboxy-Terminal Propeptide and Telopeptide to Predict Disturbances of Long-Term Mortality in Patients ≥60 Years With Heart Failure and Reduced Ejection Fraction.
Löfsjögård J; Kahan T; Díez J; López B; González A; Ravassa S; Mejhert M; Edner M; Persson H
Am J Cardiol; 2017 Jun; 119(12):2042-2048. PubMed ID: 28464988
[TBL] [Abstract][Full Text] [Related]
12. Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial.
Ravassa S; López B; Ferreira JP; Girerd N; Bozec E; Pellicori P; Mariottoni B; Cosmi F; Hazebroek M; Verdonschot JAJ; Cuthbert J; Petutschnigg J; Moreno MU; Heymans S; Staessen JA; Pieske B; Edelmann F; Clark AL; Cleland JGF; Zannad F; Díez J; González A;
Eur J Heart Fail; 2022 Feb; 24(2):321-331. PubMed ID: 34841615
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy.
Schwartzkopff B; Fassbach M; Pelzer B; Brehm M; Strauer BE
Eur J Heart Fail; 2002 Aug; 4(4):439-4. PubMed ID: 12167381
[TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study.
Izawa H; Murohara T; Nagata K; Isobe S; Asano H; Amano T; Ichihara S; Kato T; Ohshima S; Murase Y; Iino S; Obata K; Noda A; Okumura K; Yokota M
Circulation; 2005 Nov; 112(19):2940-5. PubMed ID: 16275882
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Utility of Cardiac MRI Myocardial Strain Parameters in Patients With Ischemic and Nonischemic Dilated Cardiomyopathy: A Multicenter Study.
Tang HS; Kwan CT; He J; Ng PP; Hai SHJ; Kwok FYJ; Sze HF; So MH; Lo HY; Fong HTA; Wan EYF; Lee CH; Yu EYT; Lai YTA; Lee CYJ; Leung ST; Chan HL; Tse HF; Pennell DJ; Mohiaddin RH; Senior R; Yan AT; Yiu KH; Ng MY
AJR Am J Roentgenol; 2023 Apr; 220(4):524-538. PubMed ID: 36321987
[No Abstract] [Full Text] [Related]
16. Circulating biomarkers of collagen type I metabolism mark the right ventricular fibrosis and adverse markers of clinical outcome in adults with repaired tetralogy of Fallot.
Chen CA; Tseng WY; Wang JK; Chen SY; Ni YH; Huang KC; Ho YL; Chang CI; Chiu IS; Su MY; Yu HY; Lin MT; Lu CW; Wu MH
Int J Cardiol; 2013 Sep; 167(6):2963-8. PubMed ID: 22999338
[TBL] [Abstract][Full Text] [Related]
17. Prediction of Left Ventricular Reverse Remodeling and Outcomes by Circulating Collagen-Derived Peptides.
Ravassa S; Lupón J; López B; Codina P; Domingo M; Revuelta-López E; Moreno MU; San José G; Santiago-Vacas E; Cediel G; Roncal C; Díez J; Bayés-Genís A; González A
JACC Heart Fail; 2023 Jan; 11(1):58-72. PubMed ID: 36599551
[TBL] [Abstract][Full Text] [Related]
18. Correlation of plasma TSG-6 with cardiac function, myocardial fibrosis, and prognosis in dilated cardiomyopathy patients with heart failure.
Xu L; Zhang Y; Kuang Y; Fang H; Ma Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 46(7):689-696. PubMed ID: 34382584
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of collagen type I metabolism are related to B-type natriuretic peptide, left ventricular size, and diastolic function in heart failure.
Löfsjögård J; Kahan T; Díez J; López B; González A; Edner M; Henriksson P; Mejhert M; Persson H
J Cardiovasc Med (Hagerstown); 2014 Jun; 15(6):463-9. PubMed ID: 24983265
[TBL] [Abstract][Full Text] [Related]
20. Circulating collagen metabolites, myocardial fibrosis and heart failure in aortic valve stenosis.
Kupari M; Laine M; Turto H; Lommi J; Werkkala K
J Heart Valve Dis; 2013 Mar; 22(2):166-76. PubMed ID: 23798204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
